|
|
|
LifeScienceHistory.com - Check us out on Instagram
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
OvaScience?, Inc.
| | | Phone: | (617) 500-2802 | Year Established: | 2011 | Ticker: | OVAS | Exchange: | NASDAQ | Main Contact: | Christopher Kroeger, M.D., M.B.A., CEO | | Other Contacts: | Jonathan Gillis, VP, Jonathan Gillis James Luterman, Ph.D., Executive VP, R&D
| | Company Description | OvaScience is a global fertility company dedicated to improving treatment options for women around the world. OvaScience is discovering, developing and commercializing new fertility treatments because it believes women deserve more options. Each OvaScience treatment is based on the Company’s proprietary technology platform that leverages the breakthrough discovery of egg precursor (EggPC?) cells – immature egg cells found inside the protective ovarian lining. OvaScience is developing OvaTure?, a potential next-generation in vitro fertilization (IVF) treatment that could help a woman produce healthy, young, fertilizable eggs without hormone injections and OvaPrime?, which could increase a woman’s egg reserve. OvaScience’s AUGMENT? treatment is a fertility option designed to improve IVF success rates. | |
|
|
|
|
|